Immunological dynamics in orthotopic compared with subcutaneous murine models of HPV-positive oropharyngeal cancer
Authors:
Open Access
- 1 December 2025
- journal article
- Published by The Company of Biologists in Disease Models & Mechanisms
- Vol. 18 (12)
Abstract
The necessity of reliable preclinical models for evaluating the efficacy of novel therapeutic strategies is imperative. Nevertheless, the degree to which tumor-bearing murine models represent the immunological characteristics of human papillomavirus (HPV)-positive oropharyngeal squamous cell carcinoma (OPSCC) has largely been unexplored. By utilizing single-cell RNA sequencing technology, our research elucidated that subcutaneous (SC) murine models more accurately reflect the early immunogenic phase of human HPV-positive OPSCC, marked by a stage-dependent increase in effector T-cell infiltration. By contrast, orthotopic (base of tongue, BOT) tumors exhibited a progressive decline of cytotoxic T cells and accumulation of myeloid-derived suppressive cells, paralleling the immune decrease observed in advanced, immune-excluded human tumors. Additionally, our drug responsiveness analysis indicated that early-stage BOT models more accurately replicate the response to PDCD1 blockade, whereas late-stage SC models more accurately mirror the response to CTLA4 blockade akin to human samples. Our findings provide pivotal insights into the suitability of murine models for the preclinical assessment of immunotherapies in HPV-positive OPSCC.Keywords
Funding Information
- Sichuan University
- CORE
- National Natural Science Foundation of China (82403589)
- National Natural Science Foundation of China (2023HXBH121)
- National Natural Science Foundation of China (2024HXBH111)
- National Natural Science Foundation of China (2024-YF05-00908-SN)
- National Natural Science Foundation of China (2025ZNSFSC1528)
- National Natural Science Foundation of China (2025ZNSFSC1530)
- National Natural Science Foundation of China (2024NSFSC1513)
- National Natural Science Foundation of China (2024NSFSC1510)
- West China Hospital of Sichuan University
This publication has 42 references indexed in Scilit:
- Lymphatic-localized Treg-mregDC crosstalk limits antigen trafficking and restrains anti-tumor immunityCancer Cell, 2024
- Beyond binary: bridging neutrophil diversity to new therapeutic approaches in NSCLCTrends in Cancer, 2024
- Tumor macrophage functional heterogeneity can inform the development of novel cancer therapiesTrends in Immunology, 2023
- Mature dendritic cells enriched in immunoregulatory molecules (mregDCs): A novel population in the tumour microenvironment and immunotherapy targetClinical and Translational Medicine, 2023
- Immunotherapy in HPV-Related Oropharyngeal CancersCurrent Treatment Options in Oncology, 2023
- CD8+ T cell activation in cancer comprises an initial activation phase in lymph nodes followed by effector differentiation within the tumorImmunity, 2022
- The mouse oral carcinoma (MOC) model: A 10-year retrospective on model development and head and neck cancer investigationsOral Oncology, 2022
- C1q+ macrophages: passengers or drivers of cancer progressionTrends in Cancer, 2022
- A pan-cancer single-cell transcriptional atlas of tumor infiltrating myeloid cellsCell, 2021
- Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methodsInternational Journal of Cancer, 2018